FREE CASE EVALUATION: CALL 1-800-632-1404
With media and research reports suggesting stroke and wrongful death as potential Low-T supplement side effects, there has been a spurt in testosterone lawsuit filings in the last nine months. At least 223 claims have been filed against makers of Androgel, Androderm, Depo-Testosterone, Testim, and other supplements by mid October 2014. Consumer groups are worried over increasing abuse of these drugs attributed to direct-to-buyer marketing practices by makers while studies have warned of enhanced testosterone blood clot and prostate cancer risks.
Testosterone Lawsuit
According to MDL records made public, testosterone heart risk lawsuits rose from 177 to 223 as of October 15, 2014. The complaints represent victims who have suffered heart attacks and strokes following blood clotting side effects of Low-T drugs. A significant number of AndroGel lawsuits share allegations highlighting how the supplement maker AbbVie misled consumers about its adverse impacts. A 49-year-old plaintiff from Georgia endured three heart attacks within a year of using the testosterone replacement gel. The drug used for a little over 20 weeks led a 58-year-old New York man to experience a massive heart attack. Another 60-year-old died of heart failure following use of Auxilium’s Testim gel for months.
All victims did not have any previous history of cardiovascular or diabetes problems, and they went for AndroGel hormone replacement to enhance their low sex drive and falling energy level, two signs highlighted by manufacturer-sponsored ad campaigns as key indications of depleted testosterone level.
The USJPML selected Illinois Northern District Court Judge Matthew Kennelly for pretrial consolidation and centralization of all Low-T litigations, including Androgel lawsuit, Androderm lawsuit, Axiron lawsuit, Depo-Testosterone lawsuit, Testim lawsuit, and similar claims. On October 24, a court order allowed direct filing of new individual claims in the MDL, which eliminates procedural and time delays and allows judicial efficiency in speeding up the proceedings.
The pharmaceutical industry reports indicate the possibility of such litigations running into thousands as testosterone lawyers across the country busy evaluating large number of heart attack, stroke, pulmonary embolism, and similar injury claims associated with gels, creams, patches or injections used for Low-T replacement therapy. Supplement manufacturers gained $2 billion in sales in 2013.
Testosterone Therapy Heart Attack Risk
Men using testosterone replacement therapy face the increased risk of
- blood clots (polycythemia thickens blood; thromboxane production enhances platelet aggregation)
- heart attack (36% greater risk and those already with heart problems and above 65 face two-time higher risk within 90 days, reported PLOSOne journal in January 2014)
- risk of wrongful death due to stroke (29% more risk, claims the JAMA journal in November 2013; five-timer higher risk NYT 2013)
- rampant abuse without medical need (JAMA, July 2013)
- pulmonary embolism or blockage (FDA advisory, January 2014 and Health Canada advisory July 2014)
- diabetes and metabolic problems
- worsening of existing kidney and liver disorders
In October 2014, a new study reported in Endocrinology journal warns of prostate cancer in testosterone therapy users. Attributed to scholars from Chicago-based Illinois University, it linked Low-T supplements to low-risk of prostate tumors and high risk of enhancing effect of cancer-causing agents.
At the recent FDA advisory panel meet, the Endocrine Society warned of severe side effects in men using testosterone replacement therapy without being diagnosed for hypogonadism. Its guidelines published in the Journal of Clinical Endocrinology & Metabolism flayed the practice of using these drugs to boost lifestyle.
Men unaware of adverse ramifications and induced by deceptive ad campaigns resort to using testosterone replacement therapy to reverse the effects of natural aging. This, in turn, left them with cardiovascular and metabolic problems that require life-long dietary restrictions and medical care.
If you are victim of similar injures or suffered adverse events linked to Low- T drugs, contact us or call on 1-800-632-1404 for evaluation of your potential testosterone lawsuit by our experienced drug injury lawyers.
To Contact a Testosterone Lawyer:
If you or a loved one have experienced a testosterone replacement therapy injury after undergoing low testosterone therapy, please contact our team of lawyers today for a free case evaluation at:
CALL: 1-800-632-1404
FILL OUT THIS FORM FOR A FREE CONSULTATION AND CASE EVALUATION:
NOTE: Our team of attorneys will review potential cases for all fifty states, including Alabama Alaska Arizona Arkansas California Colorado Connecticut Delaware Florida Georgia Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin and Wyoming.
One Reply to “Testosterone Lawsuit Crosses 200 Mark Amid Rising Concern Over Drug Abuse”